The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...

President Donald Trump announced on Monday that British-Swedish drugmaker AstraZeneca will be investing $50 billion in the ...

UK-based pharmaceutical giant AstraZeneca plans to build its largest drug manufacturing facility in Virginia, creating ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid US leader ...

The announcement by AstroZeneca follows a growing trend of companies pledging to invest in pharmaceutical manufacturing on ...

AstraZeneca pledges $50bn US investment ahead of drugs tariffs - Donald Trump is expected to announce tariffs of up to 200% ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint ...